Medicus Pharma Ltd: Maxim Group adjusts target price to $15 from $100 to reflect 1-for-50 reverse stock split
MDCX•Maxim Group adjusted its target price for Medicus Pharma Ltd to $15 from $100 to reflect a 1-for-50 reverse stock split.
Related News
Morgan Stanley initiates coverage of Bandwidth with equalweight rating; target price $56
BAND•
Fiera Capital Corporation: BMO cuts target price to C$5 from C$6
FSZ•
Toll Brothers plans lakefront home community in Clermont, Florida
TOL•
Money transfer firm Wise raises revenue growth outlook as cross-border volumes jump
WSE•
Espey Manufacturing selects PKF O'Connor Davies to replace Withum as auditor
ESP•